Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.

Speeding Up Percolator.

Halloran JT, Zhang H, Kara K, Renggli C, The M, Zhang C, Rocke DM, Käll L, Noble WS.

J Proteome Res. 2019 Sep 6;18(9):3353-3359. doi: 10.1021/acs.jproteome.9b00288. Epub 2019 Aug 23.

PMID:
31407580
2.

Cellular versus acellular matrix devices in the treatment of diabetic foot ulcers: Interim results of a comparative efficacy randomized controlled trial.

Tchanque-Fossuo CN, Dahle SE, Lev-Tov H, West KIM, Li CS, Rocke DM, Isseroff RR.

J Tissue Eng Regen Med. 2019 Aug;13(8):1430-1437. doi: 10.1002/term.2884. Epub 2019 May 9.

PMID:
31070860
3.

Proteomic manifestations of genetic defects in autosomal recessive congenital ichthyosis.

Karim N, Durbin-Johnson B, Rocke DM, Salemi M, Phinney BS, Naeem M, Rice RH.

J Proteomics. 2019 Jun 15;201:104-109. doi: 10.1016/j.jprot.2019.04.007. Epub 2019 Apr 10.

PMID:
30978464
4.

Comparison of protein expression levels and proteomically-inferred genotypes using human hair from different body sites.

Milan JA, Wu PW, Salemi MR, Durbin-Johnson BP, Rocke DM, Phinney BS, Rice RH, Parker GJ.

Forensic Sci Int Genet. 2019 Jul;41:19-23. doi: 10.1016/j.fsigen.2019.03.009. Epub 2019 Mar 11.

PMID:
30939338
5.

Erratum. Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes. Diabetes Care 2018;41:2361-2369.

Vaisar T, Durbin-Johnson B, Whitlock K, Babenko I, Mehrotra R, Rocke DM, Afkarian M.

Diabetes Care. 2019 Jun;42(6):1155. doi: 10.2337/dc19-er06a. Epub 2019 Apr 1. No abstract available.

6.

Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes.

Vaisar T, Durbin-Johnson B, Whitlock K, Babenko I, Mehrotra R, Rocke DM, Afkarian M.

Diabetes Care. 2018 Nov;41(11):2361-2369. doi: 10.2337/dc18-0699. Epub 2018 Aug 27. Erratum in: Diabetes Care. 2019 Jun;42(6):1155.

7.

Corneocyte proteomics: Applications to skin biology and dermatology.

Rice RH, Durbin-Johnson BP, Mann SM, Salemi M, Urayama S, Rocke DM, Phinney BS, Sundberg JP.

Exp Dermatol. 2018 Aug;27(8):931-938. doi: 10.1111/exd.13756. Review.

8.

A Matter of Time: Faster Percolator Analysis via Efficient SVM Learning for Large-Scale Proteomics.

Halloran JT, Rocke DM.

J Proteome Res. 2018 May 4;17(5):1978-1982. doi: 10.1021/acs.jproteome.7b00767. Epub 2018 Apr 6.

9.

The Beta 2 Adrenergic Receptor Antagonist Timolol Improves Healing of Combined Burn and Radiation Wounds.

Albrecht H, Yang HY, Kiuru M, Maksaereekul S, Durbin-Johnson B, Wong MS, Stevenson TR, Rocke DM, Isseroff RR.

Radiat Res. 2018 Apr;189(4):441-445. doi: 10.1667/RR14884.1. Epub 2018 Jan 26.

10.

Prevalence and risk factors for kidney stones in fibrodysplasia ossificans progressiva.

Gupta RR, Delai PLR, Glaser DL, Rocke DM, Al Mukaddam M, Pignolo RJ, Kaplan FS.

Bone. 2018 Apr;109:120-123. doi: 10.1016/j.bone.2017.12.010. Epub 2017 Dec 11.

PMID:
29241827
11.

Glucose-lowering effect of whey protein depends upon clinical characteristics of patients with type 2 diabetes.

Almario RU, Buchan WM, Rocke DM, Karakas SE.

BMJ Open Diabetes Res Care. 2017 Jul 7;5(1):e000420. doi: 10.1136/bmjdrc-2017-000420. eCollection 2017. Erratum in: BMJ Open Diabetes Res Care. 2017 Sep 26;5(1):e000420corr1.

12.

Proteomic profiling of Pachyonychia congenita plantar callus.

Rice RH, Durbin-Johnson BP, Salemi M, Schwartz ME, Rocke DM, Phinney BS.

J Proteomics. 2017 Aug 8;165:132-137. doi: 10.1016/j.jprot.2017.06.017. Epub 2017 Jun 23.

13.

Joint-specific risk of impaired function in fibrodysplasia ossificans progressiva (FOP).

Pignolo RJ, Durbin-Johnson BP, Rocke DM, Kaplan FS.

Bone. 2018 Apr;109:124-133. doi: 10.1016/j.bone.2017.06.009. Epub 2017 Jun 13.

PMID:
28627475
14.

Proteomic analysis of hair shafts from monozygotic twins: Expression profiles and genetically variant peptides.

Wu PW, Mason KE, Durbin-Johnson BP, Salemi M, Phinney BS, Rocke DM, Parker GJ, Rice RH.

Proteomics. 2017 Jul;17(13-14). doi: 10.1002/pmic.201600462. Epub 2017 Jun 23.

15.

Myasthenia gravis exacerbation after discontinuing mycophenolate: A single-center cohort study.

Dimachkie MM, Abuzinadah AR, Barohn RJ, Oskarsson B, Rocke DM, Dengel K, Richman DP.

Neurology. 2016 Nov 8;87(19):2067-2068. No abstract available.

PMID:
27821567
16.

Best Practices for Biostatistical Consultation and Collaboration in Academic Health Centers.

Perkins SM, Bacchetti P, Davey CS, Lindsell CJ, Mazumdar M, Oster RA, Peduzzi PN, Rocke DM, Rudser KD, Kim M.

Am Stat. 2016;70(2):187-194. Epub 2016 Jun 9.

17.

Demonstration of Protein-Based Human Identification Using the Hair Shaft Proteome.

Parker GJ, Leppert T, Anex DS, Hilmer JK, Matsunami N, Baird L, Stevens J, Parsawar K, Durbin-Johnson BP, Rocke DM, Nelson C, Fairbanks DJ, Wilson AS, Rice RH, Woodward SR, Bothner B, Hart BR, Leppert M.

PLoS One. 2016 Sep 7;11(9):e0160653. doi: 10.1371/journal.pone.0160653. eCollection 2016.

18.

Proteomic Analysis of Loricrin Knockout Mouse Epidermis.

Rice RH, Durbin-Johnson BP, Ishitsuka Y, Salemi M, Phinney BS, Rocke DM, Roop DR.

J Proteome Res. 2016 Aug 5;15(8):2560-6. doi: 10.1021/acs.jproteome.6b00108. Epub 2016 Jul 26.

PMID:
27418529
19.

The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global Assessment.

Pignolo RJ, Bedford-Gay C, Liljesthröm M, Durbin-Johnson BP, Shore EM, Rocke DM, Kaplan FS.

J Bone Miner Res. 2016 Mar;31(3):650-6. doi: 10.1002/jbmr.2728. Epub 2015 Nov 14.

20.

Myasthenia gravis exacerbation after discontinuing mycophenolate: A single-center cohort study.

Oskarsson B, Rocke DM, Dengel K, Richman DP.

Neurology. 2016 Mar 22;86(12):1159-63. doi: 10.1212/WNL.0000000000002405. Epub 2016 Feb 5.

Supplemental Content

Loading ...
Support Center